InvestSMART

Servcorp Limited (ASX:SRV)

ALERT: Price-sensitive ASX Announcement for SRV
Current share price for SRV : $5.200 -1.06 (-16.93%)+
Release
20 Aug 2026 9:10AM
Price at Release
$6.260
Full Release
download
Summary
Servcorp Limited reported a strong financial performance for the year ending 30 June 2026. The company achieved a statutory net profit before tax (NPBT) of $80.9 million, marking a 29% increase from the previous year. The statutory net profit after tax (NPAT) also rose by 24% to $65.6 million. Total revenue increased by 4% to $367.5 million, while underlying operating revenue reached $355.9 million. The underlying net profit before non-cash impairment of assets and tax (NPBIT) was $87.0 million, up 24% from the previous year. Servcorp maintained a strong balance sheet with net cash and cash equivalents closing at $152.4 million. The company continued to invest in its Smart Office ecosystem and IT infrastructure, advancing AI integration to enhance client and internal operations. During FY26, Servcorp opened six new operations while closing four, reallocating resources to more prestigious locations. Looking forward, the company expects underlying NPBIT guidance for FY27 to be between $85.0 million and $90.0 million, with a dividend payment not expected to fall below 34 cents per share.
Key Points
  • Statutory NPBT of $80.9 million, up 29% from the previous year
  • Statutory NPAT increased by 24% to $65.6 million
  • Total revenue rose 4% to $367.5 million
  • Underlying operating revenue reached $355.9 million
  • Underlying NPBIT was $87.0 million, up 24%
  • Net cash and cash equivalents at $152.4 million
  • Six new operations opened and four closed
  • Continued investment in Smart Office ecosystem and AI
  • FY27 guidance for underlying NPBIT between $85.0 million and $90.0 million
  • Dividend payment not expected to be below 34 cents per share
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.